01:34 PM EDT, 05/16/2025 (MT Newswires) -- Health care stocks were higher Friday afternoon, with the NYSE Health Care Index rising 1.5% and the Health Care Select Sector SPDR Fund (XLV) adding 1.7%.

The iShares Biotechnology ETF (IBB) climbed 1.3%.

In corporate news, Johnson & Johnson ( JNJ ) received approval from the UK's Medicines and Healthcare products Regulatory Agency for guselkumab to treat Crohn's disease and ulcerative colitis. Its shares rose 1%.